[Remote] Supervisor, Oncology Customer Experience at Natera

United States

Natera Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, DiagnosticsIndustries

Requirements

Candidates must possess a Bachelor's degree or equivalent, with a minimum of 3 years in customer service and 1 year in a leadership role. Proficiency in Microsoft Office, excellent attention to detail, strong organizational skills, and the ability to maintain professionalism in escalated situations are essential. Bilingual skills are preferred.

Responsibilities

The Customer Experience Supervisor will provide daily direction to team members, monitor productivity and service levels, and conduct quality checks to ensure accuracy. They will offer ongoing feedback and training, evaluate operational improvements, and conduct performance reviews. This role involves handling escalations, coaching agents, assisting with daily operations, interviewing and training new employees, and ensuring compliance with HIPAA policies and Natera's procedures for handling patient privacy.

Skills

Customer Experience Management
Team Supervision
Performance Monitoring
Quality Assurance
Training and Development
Coaching
Process Improvement
Staffing
Scheduling
Performance Appraisals
Escalation Management
PHI Handling

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI